The global Stereotactic Radiation Therapy (SRT) System market size is predicted to grow from US$ 350 million in 2025 to US$ 1541 million in 2032; it is expected to grow at a CAGR of 24.1% from 2026 to 2032.

Improvements in tumor localization, imaging and dosimetry in radiotherapy has allowed for the implementation of hypofractionated radiotherapy for disease sites where conventional fractionation (around 2 Gy per fraction) was previously the norm or where curative radiotherapy was not attempted. SRT comprises high-precision irradiation techniques that use multiple, photon radiation beams to deliver a high dose of radiation. Stereotactic localization, using frame-based or frameless techniques, is used to treat lesions. Regarding dose fractionation, SRT is divided into stereotactic radiosurgery (SRS), in which the total dose is delivered in a single treatment session, and stereotactic radiotherapy, in which the total dose is delivered in multiple fractions (usually less than 8 treatments). Originally this technique was only used when treating lesions located in the brain, however now a number of extra-cranial malignancies are treated using stereotactic localization (stereotactic body radiotherapy (SBRT)).

United States market for Stereotactic Radiation Therapy (SRT) System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Stereotactic Radiation Therapy (SRT) System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Stereotactic Radiation Therapy (SRT) System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Stereotactic Radiation Therapy (SRT) System players cover Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the Stereotactic Radiation Therapy (SRT) System Industry Forecast looks at past sales and reviews total world Stereotactic Radiation Therapy (SRT) System sales in 2025, providing a comprehensive analysis by region and market sector of projected Stereotactic Radiation Therapy (SRT) System sales for 2026 through 2032. With Stereotactic Radiation Therapy (SRT) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stereotactic Radiation Therapy (SRT) System industry.

This Insight Report provides a comprehensive analysis of the global Stereotactic Radiation Therapy (SRT) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stereotactic Radiation Therapy (SRT) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Stereotactic Radiation Therapy (SRT) System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stereotactic Radiation Therapy (SRT) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stereotactic Radiation Therapy (SRT) System.

This report presents a comprehensive overview, market shares, and growth opportunities of Stereotactic Radiation Therapy (SRT) System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    X-rays
    Gamma-rays

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Elekta
    Accuray Incorporated
    MASEP Medical Science & Technology Development (Shenzhen)
    China Isotope & Radiation Corporation
    Huiheng Group
    OUR United Gorp
    Jiangsu Rayer Medical Technology
    Hygeia Healthcare Holdings

Key Questions Addressed in this Report

What is the 10-year outlook for the global Stereotactic Radiation Therapy (SRT) System market?
What factors are driving Stereotactic Radiation Therapy (SRT) System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Stereotactic Radiation Therapy (SRT) System market opportunities vary by end market size?
How does Stereotactic Radiation Therapy (SRT) System break out by Type, by Application?